Arkadios Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Arkadios Wealth Advisors's REGN Position: Q2 2026 in Review
Arkadios Wealth Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 17% in Q2 2026, buying an estimated $524K and bringing the position to 5,205 shares worth $3.25M. The position accounts for 0.05% of the portfolio, ranked #379.
Arkadios Wealth Advisors first reported a position in REGN in Q1 2020 and has held it in 14 quarters since. The position peaked at $3.43M in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Arkadios Wealth Advisors held 5,205 shares of Regeneron Pharmaceuticals worth $3.25M as of Q2 2026.
- Arkadios Wealth Advisors bought 770 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $524K.
- Regeneron Pharmaceuticals made up 0.05% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #379 holding.
- Arkadios Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 14 quarters since.
- Arkadios Wealth Advisors's Regeneron Pharmaceuticals position peaked at $3.43M in Q1 2026.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.